‍

‍Vision Recovery Center ‍

‍

Department of Ocular Fundus Disease, Department of Glaucoma, Department of Cataract, Department of

Optometry/Ocular Surface disease, Department of Orbital Disease and Ophthalmic Plastics, Department of

Preventive Ophthalmology

      National Key Clinical Specialty
      Shanghai Municipal Clinical Medical Center for Vision Recovery 
      Shanghai municipal key discipline in leading medicine major
      Shanghai Municipal Eye Institute 
      Shanghai Jiao Tong University Eye Institute
      Vision Recovery Center

The Vision Recovery Center of Shanghai General Hospital, former Ophthalmology Department of General Hospital, was founded in 1948 by Professor Zhao Dongsheng, an ophthalmologist and the founder of retinal detachment surgery and research in China. He was renowned as "Oriental Eye". Through the joint effort of several generations including Professor Zhao Dongsheng and Professor Zhang Xi, the Ophthalmology Department grows fast. The Department became Shanghai municipal eye institute in 1985, the unit cultivating graduate students majored in ophthalmology of Fudan University Shanghai Medical College in 1986, Shanghai key discipline of ophthalmology in leading medical discipline in 1995, Shanghai Key Laboratory of Ocular Fundus Diseases in 1998, the clinical medical center for ophthalmology of Shanghai Municipality - Clinical Medical Center for Vision Recovery, and the doctoral degree and the post-doctoral station of ophthalmology of Shanghai Jiao Tong University in 2002, the training center of "Sight First China Action" of the Ministry of Health in East China and Shanghai Jiao Tong University Eye Institute in 2004, the national clinical pharmacy base of SFDA in 2007. In 2012, The Eye Image Reading Center and Biological Sample Bank of Shanghai Jiao Tong University were established. In the same year, Shanghai Municipal Center for Eye Disease Prevention and Treatment (a municipal-level specialized hospital in eye disease control and prevention) was officially entrusted to it. With 60 year hard work by several generations of experts, the department established a disease-oriented team and treatment pattern. It is capable to treat difficult eye diseases such as diabetic retinopathy, complicated cataract, keratonosus, strabismus and amblyopia. At present, by integrating medicine into teaching and research, ophthalmology has become the first-class discipline of Eye and Vision Science in domestic Grade-III Class-A general hospitals. The Department now has more than 160 beds. Its annual outpatient service and surgical cases reach 320,000 and 15,000 respectively. Its subspecialities include ocular fundus disease, cataract, glaucoma, corneal disease, refractive eye disease, strabismus, amblyopia and uveitis.

In recent five years, the Vision Recovery Center has won the Key Project of National Natural Science Fund, Key Special Scientific Project of "12th Five-Year" Plan, National Key Technology R&D Program for the "11th Five-Year" Plan, 973 Sub-project, 863 Project and 33 National Natural Science Funds, and has totally published 156 SCI papers. The research achievements were rewarded more than 25 award such as First Prize for Shanghai Science and Technology Advancement 2007, Second State Science and Technology Awards 2008, First Prize for Huaxia Science and Technology Prize 2011 and over 20 provincial and municipal-level Technology Awards.

Subspecialities  

The subspeciality of Ocular Fundus Disease has 17 members including Professor Xu Xun, Sun Xiaodong and Zheng Zhi. There are four doctoral supervisors. Those with doctorate and those with overseas study experience account for 82% and 76%. In particular, three persons are enrolled in the talent plan of the Ministry of State Human Rescource and the Ministry of Education. Two persons are leading talents of Shanghai Municipality. Professor Xu Xun is the Vice Chairman of Chinese Ophthalmological Society, chairman of Chinese Ocular Fundus Disease Group and Chairman of Shanghai Municipal Ophthalmological Society; Professor Sun Xiaodong is the Committee Member of Chinese Ophthalmological Society and Vice Chairman of Shanghai Municipal Ophthalmological Society.

The Subspeciality of Cataract and Glaucoma has 10 members under the leadership of Doctoral Supervisor Zou Haidong. Seven persons hold senior professional titles and 87% postgraduates. There are four persons enrolled into Shanghai Rising-Star Program, Rising-Star Follow-Up, Pujiang Talent and Excellent Leaders in Health System Plan respectively. Professor Zou Haidong is the Vice Chairman of National Blindness Prevention and Epidemiology of Chinese Ophthalmological Society, Vice Chairman of the Ophthalmology Branch of China Ultrasonic Engineering Association, Committee Member of Shanghai Ophthalmological Society of Chinese Medical Association.

The Subspeciality of Optometry, corneal disease, Strabismus and Amblyopia has five members under the leadership of Doctoral Supervisor Ke Bilian, including three persons with senior professional titles. All of the five persons are postgraduates. Professor Ke Bilian is the Member of Optometry Society of Shanghai Medical Association and Deputy Head of Dioptrics Group of Shanghai Ophthalmological Society.

Subspeciality of Fundus Disease in Medicine and Surgery

The specialty, founded by Professor Zhao Dongsheng in 1949, is the first domestic Specialty of Fundus Disease in Medicine and Surgery. With four Doctoral Supervisors and two master's supervisors, it is the first to treat the retinal detachment and perform operation. It conducted operations for the rhegmatogenous and traumatic retinal detachment (RD) combined with proliferative vitreoretinopathy in early 1980s in China. And domestic small package of C3F8 gas for intraocular injection as substitution of vitreous body was invented by Professor Zhang Xi in the early 1990s and was manufactured and applied to 256 units across 28 provinces and cities, totally over 20,000 cases, which filled the gap both at home and abroad. It carried out complicated RD diagnosis and treatment study to increase success rate of operation to 94％, an international leading level. Besides, it treated giant retinal tears by combining heavy water and gas injection with a success rate of 92％ in the late 1990s. It created double-ring buckling procedure to treat the recurrent retinal detachment with a success rate of 89％ and improved the classic encircled pressure procedure method to shorten the operation time by 35％. It performed internationally leading minimally invasive vitreoretinal surgery to treat the complicated retinal detachment, infectious endophthalmitis, diabetic retinopathy and various macula diseases in recent years, with a minimally invasive surgery performance rate of 92% and overall success rate of 98%. A series of vitreoretinal procedure regulations won eight technology awards including the Second Prize of China Medical Technology, the First Prize of Shanghai Clinical Medical Achievement and Award of Clinical Medical Achievement Promotion. The operations for tractive retinal detachment caused by proliferative diabetic retinopathy maintains a success rate of 92% and won the Second State Science and Technology Awards.

In terms of the treatment of the fundus disease in medicine, it performed PDT treatment and anti-VEGF treatment for more than 3,700 cases of neovascular eye diseases early in China. It treated the difficult fundus disease with both traditional Chinese and western medicine and meanwhile continuously introduced and improved the fundus disease diagnosis and treatment technology, established evaluation methods for the visual functions such as retina thickness and microperimetry, conducted treatment under microperimetry and ICGA guidance, retained fixation point, combined PDT and anti-VEGF to treat PCV and other fundus disease and won the Second and Third Prize of Shanghai Science and Technology Advancement.

Subspeciality of Cataract and Glaucoma

There are eight physicians with senior professional title, one doctoral supervisor and two master's supervisors, who are chosen to form senior Deputy Head and Secretary of Shanghai Glaucoma Group and Cataract Group. They conduct nearly 8,000 operations and serve 80,000 outpatients. It has advanced glaucoma equipments like anterior and posterior segment OCT, UBM, DCT，HRT, static and dynamic sight apparatus, several sets of the latest ultrasonic emulsification equipments like Infiniti and Signiture, and cataract-related equipments such as IOL Master. So far, it is able to perform various regular glaucoma operations, congenital glaucoma and refractory glaucoma surgeries including neovascular glaucoma, various complicated cataract operations, many types of new intraocular lens implantation procedures, combined cataract ultrasonic emulsification surgeries, combined posterior segment operations like vitreoretinal surgery and conduct comprehensive treatment for refractory glaucoma. In recent years, as the laser technology develops, in addition to the traditional laser peripheral iridectomy, it carried out numerous new laser treatment methods for glaucoma, such as selective laser trabeculoplasty and ciliary body photocoagulation under microscopic endoscope. The quantity of complicated cataract operations performed each year ranks in the top three and increases year by year. After the cataract operation, the visual recovery rate reaches nearly 99% and the rate of rehabilitation from disability reaches to 92%.

Subspeciality of Optometry, Corneal disease, Strabismus and Amblyopia

The subspecialty has six physicians with senior professional title, one doctoral supervisor and one master's supervisor, including senior Deputy Head and Secretary of Optometry, Corneal disease, Strabismus and Amblyopia Group of Shanghai Ophthalmological Society. Their daily clinical work includes amniotic membrane transplantation, punctual plugs transplanting in lacrimal duct and palpebral fissure closing procedure. Its annual outpatient visits and surgery quantity are up to 30,000 and 500 cases. Concentrated in Shanghai, its service scope has radiated to many of the surrounding areas. Meanwhile, there are also patients from Hong Kong, Macao, UK, Italy, Japan, Australia, Canada and US. In recent years, they did a large number of exploratory researches on the pathogenesis of amblyopia, including the function of the brain neurotransmitter in causing amblyopia and the brain function imaging study of amblyopia. they attach importance to the comprehensive recovery of visual function, and to recover the effective visual performance. They can successfully restore the visual system of the patient with amblyopia by comprehensive nursing like perceptual learning training. In the meantime, they apply synoptophore to rebuild the visual function that fails to develop due to ablepsia and conduct individualized amblyopia treatment and binoculus visual training with the help of the comprehensive therapy apparatus. As for paralytic strabismus, they put an emphasis on the individualized operation plan. In recent years, they cured numerous complicated paralytic, vertical, rotatory and dissocited strabismus with comprehensive treatment method by combined surgery and individualized overall design plan. They performed nearly 300 strabismus surgeries in recent three years, producing significant clinical effect. The Subspeciality undertook several projects on controlling and preventing juvenile myopia by early screening and myopia control and prevention for juvenile strabismus and amblyopia.